Successful Erlotinib Treatment for a Patient with Gefitinib-Related Hepatotoxicity and Lung Adenocarcinoma Refractory to Intermittently Administered Gefitinib

A 73-year-old Japanese man was histologically diagnosed with lung adenocarcinoma harboring an exon 19 deletion in the epidermal growth factor receptor. The patient was treated with gefitinib for 6 weeks until he developed substantially elevated hepatic enzyme levels that resulted in the discontinuat...

Popoln opis

Bibliografske podrobnosti

Principais autores:	Tatsuya Nagano, Yoshikazu Kotani, Kazuyuki Kobayashi, Masahiro Katsurada, Yukihisa Hatakeyama, Suya Hori, Daisuke Tamura, Daisuke Kasai, Yasuhiro Funada, Yoshihiro Nishimura
Format:	Artigo
Jezik:	Inglês
Izdano:	Wiley 2011-01-01
Serija:	Case Reports in Pulmonology
Online dostop:	http://dx.doi.org/10.1155/2011/812972
Oznake:	Označite Brez oznak, prvi označite!